Revisiting the pre-hypertension debate: Increasing evidence for treatment – or not?

Author： Kjeldsen Sverre E.   Hedner Thomas   Narkiewicz Krzysztof   Oparil Suzanne  

Publisher： Informa Healthcare

ISSN： 0803-7051

Source： Blood Pressure, Vol.22, Iss.6, 2013-12, pp. : 344-344

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Revisiting the prehypertension debate: Increasing evidence for treatment yet randomized clinical trials are lacking

By Reed Craig   Kwatra Shawn G.   Brown Kristine   Kwatra Madan M.  

Blood Pressure, Vol. 22, Iss. 6, 2013-12 ,pp. : 340-343

Informa Healthcare

Access to resources Recommend Favorite

Uric Acid Metabolism in Pre-hypertension and the Metabolic Syndrome

By  

Current Vascular Pharmacology, Vol. 12, Iss. 4, 2014-07 ,pp. : 572-585

Bentham Science Publishers

Access to resources Recommend Favorite

Red cell distribution width in patients with prehypertension and hypertension

By Tanindi Asli   Topal Fatih Esad   Topal Firdevs   Celik Bulent  

Blood Pressure, Vol. 21, Iss. 3, 2012-06 ,pp. : 177-181

Informa Healthcare

Access to resources Recommend Favorite

Associations of cardiovascular risk factors with prehypertension and hypertension in women

By Shimomura Tomoko   Wakabayashi Ichiro  

Blood Pressure, Vol. 21, Iss. 6, 2012-12 ,pp. : 345-351

Informa Healthcare

Access to resources Recommend Favorite

Pharmacologic Treatment for Prehypertension: To Treat or Not to Treat?

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 4, Iss. 2, 2009-06 ,pp. : 133-141

Bentham Science Publishers

Access to resources Recommend Favorite